Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2007-04-30 | Mr. Kollintzas received a Microbiology degree from the University of Illinois and a J.D. from Franklin Pierce Law Center. |
2007-08-31 | Directors and Executive Officers: Dean G. Kollintzas (5) 440,000 * |
2008-04-28 | Mr. Kollintzas joined the Board of Directors... Intellectual Property Attorney specializing in biotechnology and pharmaceutical licensing. |
2009-04-29 | Mr. Kollintzas has been an Intellectual Property Attorney specializing in biotechnology and pharmaceutical licensing. |
2010-03-12 | Dean G. Kollintzas (4) Includes options to purchase 1,820,000 shares of common stock exercisable within 60 days of March 5, 2010. |
2010-07-09 | Mr. Kollintzas has been an intellectual property attorney specializing in biotechnology and pharmaceutical licensing, FDA regulation, and corporate/international transactions. He received a microbiology degree and a J.D. from Franklin Pierce Law Center. |
2011-07-06 | Mr. Kollintzas received a microbiology degree from the University of Illinois and a J.D. from Franklin Pierce Law Center. |
2012-04-26 | Since 2001 Mr. Kollintzas has been an intellectual property attorney specializing in biotechnology and pharmaceutical licensing, FDA regulation, and corporate/international transactions. Mr. Kollintzas received a microbiology degree from the University of Illinois and a J.D. from Franklin Pierce Law Center. |
2013-04-23 | Since 2001 Mr. Kollintzas has been an intellectual property attorney specializing in biotechnology and pharmaceutical licensing, FDA regulation, and corporate/international transactions. |
2014-04-30 | Mr. Kollintzas received a microbiology degree from the University of Illinois and a J.D. from Franklin Pierce Law Center. He is a member of the Wisconsin and American Bar Associations. |
2015-03-31 | Mr. Kollintzas received a microbiology degree from the University of Illinois and a J.D. from Franklin Pierce Law Center. He is a member of the Wisconsin and American Bar Associations. |
2016-04-29 | Mr. Kollintzas is an intellectual property attorney specializing in biotechnology and pharmaceutical licensing, FDA regulation, and corporate/international transactions. |
2017-04-26 | Mr. Kollintzas is an intellectual property attorney specializing in biotechnology and pharmaceutical licensing. |
2017-06-16 | Dean G. Kollintzas (6) 214,691 * |
2018-04-27 | Since 2001 Mr. Kollintzas has been an intellectual property attorney specializing in biotechnology and pharmaceutical licensing, FDA regulation, and corporate/international transactions. |
2019-03-01 | Dean G. Kollintzas (6) 274,441 * |
2019-12-02 | Dean G. Kollintzas (6) 915 * Includes options to purchase 885 shares of Common Stock exercisable within 60 days of November 21, 2019. |
2020-07-07 | Since 2001 Mr. Kollintzas has been an intellectual property attorney specializing in biotechnology and pharmaceutical licensing, FDA regulation, and corporate/international transactions. ... Mr. Kollintzas received a microbiology degree from the University of Illinois and a J.D. from the University of New Hampshire School of Law. |
2021-06-21 | Since 2001 Mr. Kollintzas has been an intellectual property attorney specializing in biotechnology and pharmaceutical licensing, FDA regulation, and corporate/international transactions. ... Mr. Kollintzas received a microbiology degree from the University of Illinois and a J.D. from the University of New Hampshire School of Law. |
2022-06-13 | Mr. Kollintzas holds a microbiology degree from the University of Illinois and a J.D. from the University of New Hampshire School of Law. ... The Board of Directors has concluded that Mr. Kollintzas should serve on the Board of Directors due to his experience with intellectual property matters, biotechnology and pharmaceutical licensing, and FDA regulation. |
2023-06-12 | Mr. Kollintzas holds a microbiology degree from the University of Illinois and a J.D. from the University of New Hampshire School of Law. The Board of Directors has concluded that Mr. Kollintzas should serve on the Board of Directors due to his experience with intellectual property matters, biotechnology and pharmaceutical licensing, and FDA regulation. |
2024-04-15 | Mr. Kollintzas holds a microbiology degree from the University of Illinois and a J.D. from the University of New Hampshire School of Law. ... The Board of Directors has concluded that Mr. Kollintzas should serve on the Board of Directors due to his experience with intellectual property matters, biotechnology and pharmaceutical licensing, and FDA regulation. |
Data sourced from SEC filings. Last updated: 2025-07-16